Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer
Cancer Cell · 2024
DOI: 10.1016/j.ccell.2024.08.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024. Verfasst von Jiachen Xu und 59 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Ca…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Circulating Tumor DNA, Lung Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Nova Program, Chinese Academy of Meteorological Sciences, National Key Research and Development Program of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospit…
- Burning Rock Biotech, Guangzhou, China.
- Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
- Beijing Chest Hospital, Capital Medical University, Beijing, China.
- Jilin Cancer Hospital, Changchun, China.
- Liaoning Cancer Hospital & Institute, Shenyang, China.
Förderung
- Beijing Nova Program
- Chinese Academy of Meteorological Sciences
- National Key Research and Development Program of China
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Xu, J., Wan, R., Cai, Y., Cai, S., Wu, L., Li, B., Duan, J., Cheng, Y., Li, X., Wang, X., Han, L., Wu, X., Fan, Y., Yu, Y., Lv, D., Shi, J., Huang, J., Zhou, S., Han, B., …, & Feng, J. (2024). Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2024.08.013
Vancouver
Xu J, Wan R, Cai Y, Cai S, Wu L, Li B, et al. Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer. Cancer Cell. 2024. doi:10.1016/j.ccell.2024.08.013
BibTeX
@article{Xu2024,
author = {Xu, Jiachen and Wan, Rui and Cai, Yiran and Cai, Shangli and Wu, Lin and Li, Baolan and Duan, Jianchun and Cheng, Ying and Li, Xiaoling and Wang, Xicheng and Han, Liang and Wu, Xiaohong and Fan, Yun and Yu, Yan and Lv, Dongqing and Shi, Jianhua and Huang, Jianjin and Zhou, Shaozhang and Han, Baohui and Sun, Guogui and Guo, Qisen and Ji, Youxin and Zhu, Xiaoli and Hu, Sheng and Zhang, Wei and Wang, Qiming and Jia, Yuming and Wang, Ziping and Song, Yong and Wu, Jingxun and Shi, Meiqi and Li, Xingya and Han, Zhigang and Liu, Yunpeng and Yu, Zhuang and Liu, An-Wen and Wang, Xiuwen and Zhou, Caicun and Zhong, Diansheng and Miao, Liyun and Zhang, Zhihong and Zhao, Hui and Yang, Jun and Wang, Dong and Wang, Yingyi and Li, Qiang and Zhang, Xiaodong and Ji, Mei and Yang, Zhenzhou and Cui, Jiuwei and Gao, Beili and Wang, Buhai and Liu, Hu and Nie, Lei and He, Mei and Jin, Shi and Gu, Wei and Shu, Yongqian and Zhou, Tong and Feng, Jian},
title = {Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer},
journal = {Cancer Cell},
year = {2024},
doi = {10.1016/j.ccell.2024.08.013}
}
EUVIMED